Research activity

Here is a list of all the research activity pages:

Generic List

Computational cognitive neuroimaging - Behavioural neuroscience research - School of Psychology

Description
Information about research into Computational Cognitive Neuroimaging in the School of Psychology at the University of Birmingham. The goal of the Computational Cognitive Neuroimaging Group is to better understand the neural systems that allow us to acquire, represent and retrieve knowledge about our multisensory environment.

Contact - Centre in Computational Neuroscience and Cognitive Robotics

Description
CNCR, c/o School of Psychology University of Birmingham Edgbaston Birmingham B15 2TT UKTel: +44 (0)121 414 4932 Fax: +44 (0)121 414 489

Contact the ASTRAL team

Description
ASTRAL is a multicentre, randomized, unblinded clinical trial, comparing revascularisation in addition to medical therapy versus medical therapy alone in patients with atherosclerotic renovascular disease (ARVD). The aim of ASTRAL is to assess whether renal arterial revascularisation with balloon angioplasty and/or endovascular stenting can safely prevent progressive renal failure among patients with ARVD. ASTRAL closed to recruitment in October 2007 having recruited 806 patients, and is now in long term follow up until 2017. The trial is managed by the BCTU at the University of Birmingham.

Contact the eGFR-C team

Description
eGFR-C is a national multicentre prospective longitudinal study investigating the accuracy of different methods of glomerular filtration rate (GFR) estimation run by University of Birmingham Clinical Trials Unit.

Contact the Housing and Communities Research Group

Description
Contact numbers and emails for the Housing and Communities Research Group, School of Social Policy.

Contact the PD GEN team

Description
PD GEN is a DNA databank for patients with Parkinson's, from the large randomised controlled trials PD MED, PD SURG, PD REHAB & PD COMM.

Contact the PD MED team

Description
PD MED is a large randomised clinical trial investigating the clinical and cost effectiveness of the different classes of drugs in the treatment of patients with Parkinson's disease.
Displaying 61 to 70 of 102
Previous 5 6 7 8 9 Next